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Genetics of Group A Streptococci
KYU HONG CHO,1 GARY C. PORT,2* and MICHAEL CAPARON2
Department of Biology, Indiana State University, Terre Haute, IN 47809; 2Department of Molecular
Microbiology, Washington University School of Medicine, Saint Louis, MO 63110

ABSTRACT Streptococcus pyogenes (group A streptococcus) is
remarkable in terms of the large number of diseases it can cause
in humans and for the large number of streptococcal factors
that have been identiﬁed as potential virulence determinants
for these diseases. A challenge is to link the function of potential
virulence factors to the pathogenesis of speciﬁc diseases. An
exciting advance has been the development of sophisticated
genetic systems for the construction of loss-of-function,
conditional, hypomorphic, and gain-of-function mutations in
targeted S. pyogenes genes that can be used to test speciﬁc
hypotheses regarding these genes in pathogenesis. This will
facilitate a mechanistic understanding of how a speciﬁc gene
function contributes to the pathogenesis of each streptococcal
disease. Since the ﬁrst S. pyogenes genome was completed
in 2001, hundreds of complete and draft genome sequences
have been deposited. We now know that the average S. pyogenes
genome is approximately 1.85 Mb and encodes ∼1,800 genes and
that the function of most of those genes in pathogenesis remains
to be elucidated. However, advances in the development of a
variety of genetic tools for manipulation of the S. pyogenes
genome now provide a platform for the interrogation of gene/
phenotype relationships for individual S. pyogenes diseases,
which may lead to the development of more sophisticated
and targeted therapeutic interventions. This article presents
an overview of these genetic tools, including the methods of
genetic modiﬁcation and their applications.

INTRODUCTION
Streptococcus pyogenes (the group A streptococcus) is
remarkable in terms of the large number of very different
diseases it can cause in humans. These range from superﬁcial and self-limiting diseases of the pharynx (e.g.,
pharyngitis, commonly known as strep throat) and skin
(impetigo) to infections that involve increasingly deeper
layers of tissue and are associated with increasing degrees
of destruction of tissue (e.g., erysipelas, cellulitis, necrotizing fasciitis, and myositis). The organism has the ability to spread rapidly through tissue and to penetrate into
the vasculature to cause lethal sepsis. Other diseases
ASMscience.org/MicrobiolSpectrum

result from the production of toxins that spread through
tissue or spread systemically from a site of local infection
(scarlet fever and toxic shock syndrome). Still other diseases are the result of an immunopathological response
on the part of the host that is triggered by a streptococcal
infection. These diseases include rheumatic fever, acute
glomerulonephritis, certain types of psoriasis, and potentially even some forms of obsessive-compulsive syndrome disorder (pediatric autoimmune neuropsychiatric
disorders associated with streptococcal infections).
S. pyogenes is even more remarkable in terms of the
large number of factors that have been identiﬁed as potential virulence determinants for these various diseases.
These include surface proteins (M proteins, ﬁbronectinbinding proteins, surface dehydrogenases, C5a peptidase), the hyaluronic acid capsule, secreted degradative
enzymes (several distinct DNases, a cysteine protease,
NAD+-glycohydrolase, hyaluronidases,) and many secreted toxins (streptolysin S, streptolysin O, the pyro-
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genic exotoxins, streptococcal superantigens, streptokinase). This is only a partial list of the potential virulence factors this bacterium can produce, and many of
these are considered in more detail elsewhere.
Until recently, the function that any of these potential
virulence factors contributed to the pathogenesis of any
speciﬁc streptococcal disease was only poorly understood.
A major reason for this deﬁciency was the lack of sophisticated genetic systems that could be applied to the
analysis of a speciﬁc virulence factor according to modern
molecular criteria. These criteria were succinctly outlined by Falkow in his “Molecular Koch’s Postulates”
(1). These state that (i) the phenotype under investigation should be associated with pathogenic members of a
species, (ii) the gene(s) associated with the virulence trait
should be identiﬁed and isolated by molecular methods,
(iii) speciﬁc inactivation of identiﬁed gene(s) should lead
to a measurable loss in pathogenicity, and (iv) reintroduction of the unmodiﬁed wild-type gene should lead to
a restoration of pathogenicity. An exciting development
is that, over the past several decades, the work of many
groups has contributed to the development of sophisticated group A streptococcal genetic systems that now
allow the many diseases that this organism can cause
to be studied at this level of molecular resolution. The
modern S. pyogenes genetic modiﬁcation systems are
supported by the numerous complete genome sequences
now available. Since the ﬁrst complete genome sequence
of an S. pyogenes strain in 2001 (2), 61 complete genome sequences and approximately 300 draft sequences
have been deposited as of March 2018 (3). The average
S. pyogenes genome is approximately 1.85 Mb and encodes ∼1,800 genes, the function of many of which remains to be elucidated (4). The other major advance has
been in the development of a variety of genetic tools
aimed at manipulating the S. pyogenes genome. The goal
of this article is to present an overview of these tools,
including the methods of genetic modiﬁcation and their
applications.

GENETIC EXCHANGE
Transduction
A key element of any genetic system involves some system
of genetic exchange between bacterial hosts, allowing the
construction of an altered genome in the target host
which can then be subjected to an analysis of its virulence
phenotypes. Unlike several other species of streptococci,
the group A streptococci are not naturally competent for
the uptake of exogenous DNA, even though their genomes
encode many of the genes required for transformation
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(see below). Conjugative DNA transfer does occur in
group A streptococci; however, this is restricted to the
transfer of conjugative plasmids and conjugative transposons (see below), and there is no evidence of mobilization of chromosomal markers. There is also no evidence
that any important virulence traits are encoded by these
types of mobile elements, although they are undoubtedly
important in the transmission of resistance to various
antibiotics.
Even though there is no evidence to support genetic
exchange by transformation or by conjugation, analysis
of several polymorphic loci, most notably the genes which
encode the M proteins and the fibronectin- and collagenbinding proteins and T antigen (FCT)/pilus region have
provided considerable evidence of horizontal transfer of
genetic material among natural populations of S. pyogenes (5). In this regard, considerable attention has been
focused on the contribution of phage to genetic transfer
(5). S. pyogenes strains are rich in phage, and several of
these have been demonstrated to encode virulence factors, including the pyrogenic exotoxins SPE-A and SPE-C
(6). Thus, it is not surprising that transduction was the
ﬁrst mechanism of genetic exchange that was exploited
in the manipulation of the S. pyogenes genome (7). The
most highly developed of these are derivatives of phage
A25. This lytic phage is classiﬁed as a Bradley group B
phage that recognizes the peptidoglycan of groups A, C,
and G streptococci as its cellular receptor. It has a 35-kb
double-stranded genome with circular permutation and
terminal repetition (8), and it is proﬁcient in transducing
markers in vitro (for a detailed description of a method of
transduction, see reference 9). The most useful derivatives of A25 for use in transduction are those developed
by Malke and colleagues, who constructed a derivative
with two distinct temperature-sensitive lesions (A25ts1-2)
that becomes defective for growth at 37°C (10). This
feature is useful for transduction, since it allows the
production of a transducing lysate of the donor host at
the permissive temperature (30°C) but prevents the killing of transduced hosts when infection is performed
at the nonpermissive temperature. The A25 phage was
used in some of the ﬁrst mutagenesis studies in group
A streptococci, including the original identiﬁcation of
Mga, the master regulator of M protein (7). In spite of the
early use of this method, genetic manipulation via phage
transduction is inherently limited in application since it
requires preexisting antibiotic resistance markers within
or near genes of interest. Additionally, some phage possess narrow host speciﬁcities, thereby limiting their utility
to only a few strains. Furthermore, phage transduction
can be laborious. Fortunately, simpler and more rapid
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genetic engineering methods, including electroporation of
shuttle plasmids and saturating transposon mutagenesis,
have largely replaced phage transduction (see below).

Transformation
One of the most signiﬁcant advances in genetic technology for S. pyogenes has been the development of methods
for transformation. This has allowed the introduction
of heterologous DNA into an S. pyogenes host and has
opened the door to a large number of techniques for
mutagenesis and allelic exchange that are described in
greater detail below. The breakthrough technology that
began the era of transformation for S. pyogenes was the
introduction by several companies of reasonably priced
instruments for the introduction of DNA by electroporation. As is true for most methods of transformation,
success with electroporation-based transformation results
from careful attention to growth conditions. Electroporation of streptococci generally requires that the cell walls be
weakened. Most successful methods have adapted the
techniques originally developed by Dunny and colleagues
for electroporation of the enterococci (11). This method
uses cells from the early exponential stages of growth in
medium supplemented with glycine. The addition of glycine is thought to contribute to a decreased level of crosslinking in the cell wall, and the exact stage of growth and
concentration of glycine is determined empirically (for
a detailed description of the method, see references 9,
12–14).
It is of interest to note that the genomic sequences of
several S. pyogenes strains of the M1, M3, and M5 serotypes have revealed that while they have genes required
for DNA uptake by natural transformation and that
while these genes are expressed in response to a peptide
pheromone, they remain nontransformable (15). In addition, a cluster of genes associated with the ability to
cause disseminated infection, called the Sil locus, contains genes highly homologous to the comAB competence locus (16). To date, the Sil genes have only been
found among serotype M14 and M18 strains, and since
their G+C content is markedly lower than the rest of the
S. pyogenes chromosome, they may have been more recently acquired by these lineages from horizontal transmission (17).

Plasmid Technology
The development of efﬁcient transformation systems has
allowed for the rapid genetic modiﬁcation of S. pyogenes hosts through the introduction of plasmids into S.
pyogenes. Applications include (i) construction of chromosomal allelic replacements, gene deletions, and site-
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speciﬁc mutations; (ii) complementation of chromosomal
mutations in trans; (iii) analysis of reporter gene expression; and (iv) delivery of transposable elements to
construct random mutant libraries for forward genetic
screens. Common Gram-negative plasmid replicons (including pUC, pBR322, and pSC101) are unable to replicate in Gram-positive species and can therefore serve
as “suicide” delivery vectors for transposon delivery or
recombination-based chromosomal integrative elements
(see below). Also, many of the plasmids which have
proven useful for genetic analysis in other Gram-positive
species, including pC194, pE194, and pUB110, appear
unable to replicate reliably in S. pyogenes. Fortunately, a
handful of plasmids have been identiﬁed that do replicate
in S. pyogenes, and these plasmids have been engineered
over the past 20 years to give rise to a growing set of tools
aimed at manipulating the S. pyogenes chromosome
(Table 1).
The most widely used plasmid for S. pyogenes genome
engineering is derived from pWV01 (18). This plasmid
was isolated from a lactococcal species and is the prototype member of a family of “promiscuous replicons”
that have the remarkable property that they can replicate
in both Gram-negative (e.g., Escherichia coli) and Grampositive (e.g., S. pyogenes) hosts. pWV01 replicates using a rolling-circle type mechanism characteristic of many
single-stranded bacteriophages and likely exists in a singlestranded conformation for extended periods of time in
replicating cells. This can have consequences for plasmid
structural integrity, segregation instability, and expression of open reading frames inserted for complementation or ectopic or orthogonal expression (19). Common
derivatives of pWV01 include plasmids such as pABG5
(Fig. 1), which include an S. pyogenes promoter for ectopic or orthogonal expression (20), and the high-copy
variant pBAV1kT5, which lacks a set of inverted repeats
and an open reading frame thought to be responsible for
copy number regulation (21). A versatile and widely used
derivative of pWV01 known as pG+host4 was developed
by Maguin and coworkers to contain a temperaturesensitive (ts) replicon (22). The plasmid contains four
amino acid substitutions in the RepA protein, which is
responsible for nicking one DNA strand at the plus origin
to initiate replication, thus rendering the process temperature sensitive. Subsequent derivatives of this plasmid
include pJRS233 (23) and pGCP213 (24), which add low
copy (pSC101) or high copy (ColE1/pUC) thermo-stable
Gram-negative replication origins, respectively, to facilitate various applications for subcloning and plasmid
propagation in E. coli. In addition, pGCP213 includes
a full-length gene encoding LacZ containing the multi-
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TABLE 1 Common plasmids utilized for S. pyogenes genome engineering
Capability

Name

Ori G+/G–

Site-directed
mutagenesis

pJRS233

pWV01 ts/pSC101 ermC

pGCP213

pWV01 ts/pUC
(pBR322)
pWV01 ts/pUC
(pBR322)
pWV01 ts/pUC
(pBR322)
pWV01 ts/NA

pCRK
pCRS
pHY304
pSinS/pHlpK

aphA3
aad9
ermC

aad9

pGCP189

pWV01 ts/pSC101 ermC

pMGC57TnErm
EZ-Tn5
pOSKAR

NA/pHSG396
(pBR322)
NA/NA
pWV01 ts/pUC
(pBR322)
pWV01 ts/pUC
(pBR322)
pWVO1/NA
pWV01

pKRMIT
Reporter

ermC

pCRS (ΔrepA)
aad9/aphA3
pCRK (ΔpUC)
pWV01/NA
aphA3/catA
NA/pUC (pBR322) ermC

Complementation pABG5
p7INT, p7INTa
(pGCP365)
pEU7742
pAMβ1/NA

Transposon

Ab cassette(s)

pGCP070
pWAR303

catA/ermC (for Tn)

Features

Reference(s)

Low copy (E. coli) thermosensitive shuttle
vector
High copy (E. coli) thermosensitive shuttle
vector
High copy (E. coli) thermosensitive shuttle
vector
High copy (E. coli) thermosensitive shuttle
vector
Thermosensitive vector, must be grown
at 30°C
Conditional suicide plasmid pSin stabilized
by temperature-sensitive helper plasmid
Thermostable shuttle vector, ProfA promoter
Integrates into prophage tmRNA attB site

23

Single copy with toxin/antitoxin, contains
theophylline-inducible riboswitch and gusA
reporter
Insert gene of interest downstream of GuaB
in synthetic polycistron
Tn4001

24
25
25
111
42
20
33, Port, Caparon
Unpublished
32

45
80

ermC
Tn5
43
aad9/aphA3 (for Tn) Mariner Kan-Tn ﬂanked by T7 For microarrary 25
TraSH
aad9/aphA3 (for Tn) Mariner Kan-Tn ﬂanked by MmeI For TnSeq
42
aphA3/catA
ermC

TetR inducible sfGFP
Luciferase LuxAB

100
112

ple cloning site from pCR2.1 (Invitrogen), allowing for
blue/white screening of insertions via α-complementation
in E. coli. Plasmids pCRS and pCRK are similar to
pGCP213, differing primarily in their antibiotic resistance cassettes (25). The modiﬁcations to the standard
electro-transformation conditions described by Scott’s
group greatly increase the transformation efﬁciency of
these ts plasmids (23). The main application of the pG+
host-derived ts plasmids has been in the construction of
in-frame deletions and allelic replacement to introduce
site-speciﬁc mutations of chromosomally encoded genes
and in the delivery of transposable elements for mutagenesis (see below).
These plasmid-based methodologies can be adapted
for functional studies to validate the contribution a given
gene confers to a given phenotype via expression in a
heterologous host. The heterologous host can be an S.
pyogenes strain which naturally lacks the phenotype
under investigation or can be another streptococcal or
enterococcal species. In one of the ﬁrst examples of this
strategy, Scott and Fischetti’s group introduced a copy of
the gene which encodes the M6.1 protein (emm6.1) on
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a mobilizable plasmid vector, used this to transform a
naturally competent streptococcal species, and then mobilized the plasmid by conjugation into an emm-deﬁcient
S. pyogenes host (26). Analysis of the resulting strain
demonstrated that the introduction of emm6.1 converted
the host strain from being sensitive to killing in a bactericidal assay to being resistant to killing in the assay. This
study was the ﬁrst formal application of Falkow’s molecular Koch’s postulates to S. pyogenes pathogenesis
(26). Additional applications of this approach have included the demonstration that protein F is sufﬁcient to
confer a ﬁbronectin-binding phenotype to non-ﬁbronectinbinding S. pyogenes and enterococcal hosts (27) and that
the has operon is sufﬁcient to confer the ability to produce
hyaluronate to both acapsular S. pyogenes and enterococcal hosts (28).
The second class of commonly used vectors in S. pyogenes was based on the low-copy pAMβ1 replicon originally isolated from Enterococcus faecalis (29). Unlike
pWV01, the pAMβ1 replicon cannot replicate in E. coli,
so derivatives have been engineered to contain an origin
of replication that is proﬁcient in an E. coli host (19). The
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aCommon antibiotic markers used in group A streptococcus mutagenesis include aad9 (spectinomycin resistance, Spr), catA (chloramphenicol resistance, Cmr), aphA3
(kanamycin resistance, Kmr) and ermC (erythromycin resistance, Emr). Because group A streptococcus remains sensitive to penicillin and is a preferred clinical treatment, the use
of β-lactamase for selection during group A streptococcus mutagenesis is both unethical and prohibited.

FIGURE 1 A chimeric secreted alkaline phosphatase reporter
gene. The plasmid pABG5 is a pWV01-based E. coli-streptococcal
shuttle vector which encodes resistance to chloramphenicol
(cat) and kanamycin (aphA3). The plasmid contains a promoterless reporter gene formed by the fusion of the N-terminal
region of the cell wall-associated protein F (prtF*) to the enzymatic domain of the enterococcal alkaline phosphatase
(*phoZ). Since the chimeric protein (secreted protein F-PhoZ
reporter, or PhoZF) lacks the C-terminal cell wall attachment
domain of protein F and the N-terminal lipoprotein tethering
domain of PhoZ, it is freely secreted from the cell. The PhoZF
chimera retains the enzymatic activity of PhoZ and can be
easily quantitated in culture supernatants. Restriction sites for
BglII or BamHI and EcoRI can be used to place the promoter of
interest in an orientation to direct transcription of phoZF, which
is then translated using the ribosome-binding site of prtF (RBS).
Insertion of an open reading frame of interest between the
EcoRI and either the ClaI or PstI site places the open reading
frame under the control of the strong rofA promoter for ectopic expression and/or complementation analyses.

plasmid pAT28 developed by Courvalin’s group (30) is
typical of the pAMβ1-derived vectors and contains the
high-copy pUC replicon derived from ColE1 for replication in E. coli and several other useful features including
the multiple cloning site and the lacZα reporter gene of
pUC18, which allows screening for insertion of cloned
DNA by α-complementation in E. coli (30). In contrast to
the rolling circle replication of pWV01, pAMβ1 replicates
via a double-stranded θ-type mechanism which typically
leads to greater plasmid stability. Also, as a general rule,
pWV01-based vectors transform S. pyogenes at a much
higher efﬁciency than do pAMβ1-derived vectors. Because

ASMscience.org/MicrobiolSpectrum

of their different modes of replication, this difference may
involve how the restriction system of S. pyogenes recognizes the two plasmids. However, it should be noted
that very little is currently understood about restriction in
S. pyogenes and that, in general, it has not posed a signiﬁcant barrier to the introduction of DNA puriﬁed from
any number of different E. coli K12 hosts. Despite its
lower transformation efﬁciency, the pAMβ1-derived vectors have proven very useful in obtaining expression of
cloned genes that were only poorly expressed by pWV01based vectors (31). A useful derivative of pAMβ1 is
pEU7742 (32), which includes a toxin-antitoxin cassette
(axe-txe) from an Enterococcus faecium plasmid for enhanced plasmid stability.
An alternative to using replicating plasmids for expression of heterologous genes or genes in trans is the
vector system known as p7INT, which contains an E.
coli origin of replicon to facilitate manipulation in E. coli,
along with the integrase gene (int) and attachment site
(attP) from the T12 temperate bacteriophage of S. pyogenes (33) (Fig. 2). Following its introduction into S.
pyogenes, int catalyzes the site-speciﬁc recombination of
the entire circular molecule into the chromosomal phage
T12 attachment site (attB) located at the 3′ end of the
transfer-messenger RNA gene (33) by a mechanism resembling integration of lambda phage (34). Because the
plasmid lacks the phage excisionase, integration is highly
stable. Derivatives of p7INT have been used to study
Rgg-dependent gene regulation through use of a luxAB
luciferase-based reporter system (35). It should be noted
that integration of p7INT is strain speciﬁc, because two
alleles of transfer-messenger RNA (tmRNA) exist among
the published sequences, which are distinguished by a
single nucleotide polymorphism in attB. Common strains,
including NZ131 and HSC5, have an attB site compatible
for p7INT integration, while others, including JRS4, have
an incompatible site. However, p7INT can be modiﬁed by
a single base change, generating p7INT*, which can integrate into the alternative attB site (G.C. Port and M.G.
Caparon, unpublished) (Fig. 2).

DIRECTED MUTAGENESIS
The techniques developed for directed mutagenesis (reverse genetics) in S. pyogenes have proven invaluable for
the analysis of the contributions that speciﬁc genes make
to pathogenesis. In this approach, a deﬁned mutation is
constructed to inactivate, or in some cases modify, a
speciﬁc gene to construct an isogenic mutant strain for
analysis. These techniques have become particularly useful with the availability of the complete or draft genome
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FIGURE 2 p7INT and p7INT*. The plasmids p7INT and p7INT* are pUC18-based E. coli
vectors that encode resistance to erythromycin (erm). Restriction sites for BamHI, ClaI,
SmaI, and EcoRI within lacZ can be used to insert any promoter and gene of interest for
ectopic expression and/or complementation analyses. The plasmids also contain a phage
integrase (INT) and an attP sequence which targets integration into the S. pyogenes
chromosome at the 3′ end of the tmRNA locus within the 96-bp “O” site of POP′ and BOB′
of attP and attB, respectively. With respect to O sites, S. pyogenes has been found to
contain one of two alleles with either an A or G (see text). Plasmid p7INT contains an A,
whereas p7INT* has been mutated to contain a G, and the appropriate plasmid must be
used depending on the allele found within the S. pyogenes strain of interest. Following
introduction of the appropriate plasmid into S. pyogenes, selection for the antibioticresistant determinant of the plasmid (erm) selects for chromosomes in which the plasmid has integrated into the chromosome at the attB site. The distribution of tmRNA and
tmRNA* between a selection of commonly used strains is shown, with GenBank accession numbers as follows: HSC5, CP006366.1; SF370, AE004092.2; Manfredo, AM295007.1;
MGAS10270, CP000260.1; MGAS5005, CP000017.2; MGAS6180, CP000056.1; MGAS10750,
CP000262.1; MGAS2096, CP000261.1; MGAS9429, CP000259.1; NZ131, CP000829.1; JRS4,
CP011414.1; MGAS8232, AE009949.1; MGAS10394, CP000003.1; MAGS315, AE014074.1;
SSI-1, BA000034.2.
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sequences of S. pyogenes (3). In the following, we consider methods to alter or inactivate a targeted gene on
the S. pyogenes chromosome using (i) allelic replacement
using linear DNA, (ii) directed insertional integration,
and (iii) construction of in-frame deletion alleles.

Allelic Replacement Using Linear DNA

ASMscience.org/MicrobiolSpectrum

FIGURE 3 Strategy for allelic replacement mutagenesis using
linear DNA. Segments of DNA homologous to the 5′ and 3′
ends of the target gene are placed ﬂanking a gene encoding
a selectable antibiotic resistance gene, typically on a standard
plasmid vector using E. coli-based molecular cloning technology. The resulting E. coli plasmid vector is converted to a
linear molecule by PCR or by digestion using restriction enzymes with sites outside of the cloned streptococcal gene
(vector DNA is represented by the curved lines) and introduced
into S. pyogenes with selection for resistance to the antibiotic
encoded by the introduced resistance gene. Recombination
between the two homologous sequences (indicated by the
lines between the introduced DNA and chromosome) results
in the replacement of the insertionally inactivated allele for
the native chromosomal allele (shown below the arrow).

because the frequency of nonhomologous recombination
is typically extremely low. Insertion into the expected locus is conﬁrmed using PCR-based analyses and/or genome
sequencing, and the resulting mutant can be subjected to
functional studies. However, in interpreting the resulting functional data, it should be kept in mind that this
method of mutagenesis generates strong polar mutations. Thus, expression of distal genes should be examined using quantitative real-time reverse transcriptase PCR
(qRT-PCR) or other methods suitable for analysis of gene
expression.
A variation of this technique can be used to subject a
large cloned region to rapid high-resolution insertional
mutagenesis, which can be useful for analyses of complex
phenotypes and pathways whose genes are often clustered
together on the chromosome. This method uses a version
of the E. coli transposon mini-γδ (mγδ-200) that has been
modiﬁed to contain a kanamycin-resistance gene that can
be selected for in both E. coli and S. pyogenes. Called
“shuttle mutagenesis,” this technique uses the ability of
m-γδ to easily and efﬁciently generate a large number
of random transposon insertions into a segment of DNA

7

Downloaded from https://journals.asm.org/journal/spectrum on 06 January 2022 by 128.252.174.220.

This method of mutagenesis is straightforward and involves ﬁrst cloning the gene of interest into any suitable
plasmid vector in E. coli. With the available genome information, this has become a simple task of analyzing
the sequence and designing suitable primers for PCR
ampliﬁcation, followed by insertion of the ampliﬁcation
product into an E. coli cloning vector. As a general rule,
S. pyogenes DNA is most stable when cloned on lowcopy vectors in E. coli, and several vectors have been
used with great success. The standard PCR methodology is then used to insert a selectable marker into the
open reading frame to inactivate it. The markers that
have been most successful are those derived from Grampositive organisms that can also be used for selection
in E. coli and include ermC (resistance to erythromycin;
GenBank accession no. NG_047805.1), aphA3 (resistance to kanamycin; GenBank accession no. V01547.1),
tetM (resistance to tetracycline; GenBank accession no.
X92947.2), aad9 (resistance to spectinomycin; GenBank
accession no. M69221.1), and catA (resistance to chloramphenicol; GenBank accession no. NG_047564.1). It
should be noted that because resistance to β-lactam antibiotics does not naturally exist among clinical S. pyogenes isolates, for ethical reasons, genes encoding any
type of β-lactamase must not be used for this application. Strong polar mutations can be introduced through
the use of dedicated insertional mutagenesis cassettes,
such as the Omega interposon (ΩKm-2), which contains
strong transcription and translation termination signals
(36). Following its construction, the insertionally inactivated allele is converted to a linear molecule by PCR
ampliﬁcation or restriction digestion of the backbone
plasmid. The resulting linear molecule is then used to
transform the target S. pyogenes host with selection for
the inserted resistance marker. Transformation of linear
DNA is best conducted using highly puriﬁed salt-free
DNA (for example, see 37). Because the introduced molecule is linear, preservation of the circular chromosomal
structure requires that all resistant transformants arise by
two homologous recombination events ﬂanking each side
of the inserted resistance marker. The end result is the
exchange of the wild-type allele for the inactivated allele
(Fig. 3). While this type of recombination does not occur at high frequency, the method is usually successful

cloned on a plasmid to obtain a series of mutations along
the entire length of the cloned streptococcal DNA. These
sets of nested insertions are then crossed into the streptococcal chromosome as described above. This method
has been successfully used to identify regulatory genes
linked to a target gene of interest (38). For a detailed description of this technique, consult Hanski et al. (39).

Directed Insertional Inactivation
A commonly used technique for directed mutagenesis
employs mutations constructed as the result of a single
homologous recombination event. For this technique, an
internal segment of the target gene lacking the 5′ and
3′ ends is cloned into a Gram-negative restricted plasmid.
A selectable marker for S. pyogenes is also included on
the plasmid located adjacent to the cloned segment, but
this marker should not be a β-lactamase (see above). As a
general rule, the larger the fragment that is ampliﬁed, the
greater the frequency at which allelic exchange occurs,
although this method has been successful with fragments
in the 250- to 500-bp range. The resulting plasmid is
puriﬁed from E. coli and used to transform S. pyogenes
with selection for resistance to the introduced marker.
Because the commonly used E. coli replicons do not
replicate in S. pyogenes, resistant transformants most
frequently arise as a result of a single homologous recombination event between the internal segment of the
gene introduced on the plasmid and the identical sequence on the streptococcal chromosome. The resulting
chromosomal structure is generated by integration of the
entire plasmid and consists of a partial duplication of the
target gene, which now ﬂanks the integrated plasmid
sequences (Fig. 4A). As a consequence of using only an
internal fragment of the target gene, one of the duplicated copies lacks its 3′ end and the other lacks its 5′ end
such that both partial copies should be inactive. Thus,
the end result is the directed insertional inactivation of
the target gene. A number of modiﬁed E. coli plasmids
have been utilized for this mutagenesis technique, often
by replacing a β-lactamase ampicillin cassette for an appropriate selection marker. These include pCIV2 (40) and
pSPC18 (41), which contain a kanamycin and spectinomycin resistance cassette, respectively.
The principal advantage to this method is that single recombination events are relatively quick and easy
to generate because they require a single selection step
rather than the multiple passages and screening required
for construction of in-frame deletions using ts shuttle
vectors (see below). This approach is also simple because
it requires the cloning of only a single segment of the
chromosome and can work with fragments as small as

8

0.25 kb. However, there are several disadvantages to the
method. These include the possibility that the mutations
are not necessarily stable because a second recombination event between the duplicated gene segments can
result in excision of the plasmid vector and regeneration of a wild-type structure. Also, because the incoming
plasmid does not replicate, it has only a limited period
of time with which to undergo recombination for insertion into the chromosome. This latter limitation was
addressed by Le Breton et al., who devised a two-plasmid
system whereby a suicide plasmid (pSinS) lacking the
pWVO1 RepA is complemented by a helper plasmid
(pHlpK) that provides a ts RepA. The two plasmids are
used to transform S. pyogenes at a permissive temperature, and a subsequent shift to a higher temperature
prevents plasmid replication, selecting for plasmid integration (42). A ﬁnal limitation to discuss is that the mutations generated by this technique are strongly polar.
However, it is possible to modify the technique to directly assess the impact of polarity on the phenotype under investigation. In this case, an additional control strain
is constructed, where instead of cloning a segment internal to the target gene, a segment is cloned that has its 5′
end anchored internal to the gene, but its 3′ end is anchored at a location distal to the 3′ end of the coding
region of the gene. Integration of this construction into
the target gene in a wild-type strain also results in a partial duplication. However, because the cloned segment
overlaps the 3′ end of the gene, the ﬁrst copy of the gene
is regenerated and the integrated vector is located adjacent to this intact copy such that it is still polar on expression of any distal genes (Fig. 4B). If the phenotype
under analysis is the result of a polar effect and the loss of
expression of a distal gene, then this control strain should
also demonstrate the mutant phenotype, even though it
has an intact and functional copy of the target gene. On
the other hand, an unaltered wild-type phenotype in the
control strain indicates that the mutant phenotype is
solely the result of insertional inactivation of the target
gene (for example, see 43).
An additional modiﬁcation of this method can be used
to map the promoter and cis-acting control regions of a
target operon. This is based on the technique developed
by Moldover and colleagues (44) for analysis of promoters in Bacillus subtilis and is similar in concept to the
method described above for placing a polar insertion
downstream of a target gene. However, in this technique,
the segment of DNA cloned into the integrational vector
is anchored within the coding region at its 3′ end but is
anchored upstream of the start of the gene at its 5′ end.
Integration of this construct into the target locus again

ASMscience.org/MicrobiolSpectrum

Downloaded from https://journals.asm.org/journal/spectrum on 06 January 2022 by 128.252.174.220.

Cho et al.

Genetics of Group A Streptococci

generates duplication. However, since the 3′ end of the
cloned segment ends within the gene, the ﬁrst copy is
truncated and is inactive. This is followed by the integrated vector and then by the second intact copy of the
target gene, which is now preceded exactly by the 5′
ﬂanking region cloned into the vector. If this 5′ ﬂanking
region includes the promoter and other cis-acting control regions, the target gene will be expressed (Fig. 4C-1).
If this segment lacks these elements, the target gene
will not be expressed (Fig. 4C-2). By using a nested set of
insertions containing different lengths of the upstream
control region, it is possible to map the sequences required for expression and regulation of the target gene
with a high degree of precision. This method has been
used to examine regulation of mga, the regulator of the
genes which encode the M proteins and the C5a peptidase (40).

Shifting the culture back to the permissive temperature
enriches for chromosomes from which the plasmid has
been excised, since replication of the integrated plasmid
creates a second origin of replication for the chromosome, which is usually deleterious to growth. The culture
is once again shifted to the nonpermissive temperature,
but this time in the absence of selection for the plasmid.
This enriches for segregants, which have lost the excised
and now nonreplicating plasmid. These segregants are
plated as single colonies, which are then examined by
streaking each colony onto agar plates in the presence or
absence of antibiotic selection to identify clones which
have lost the plasmid and thus are sensitive to the antibiotic used for selection. These are typically subjected
to further screening by PCR and/or genome sequencing
to identify chromosomes which contain the in-frame
deletion allele. For a detailed description of this technique see Le Breton and McIver (12).

In-Frame Deletion

ASMscience.org/MicrobiolSpectrum

Counterselection Markers
The requirement for multiple passages at nonpermissive
and permissive temperatures can make this method of
in-frame deletion time-consuming. However, counterselection strategies that select against the retention of the
plasmid can be used to expedite the recovery of chromosomes that have undergone plasmid excision and loss
(50). One such strategy involves phenylalanyl tRNA synthetase (alpha-subunit) encoded by pheS. A single amino
acid substitution in PheS (PheS*) confers relaxed substrate speciﬁcity and allows for the misincorporation of a
toxic derivative of phenylalanine, 4-chloro-phenylalanine
(4CP), into proteins. Here, a plasmid containing pheS*
is integrated into the chromosome. Subsequent culture
in the presence of 4CP results in the death of cells that
retain the pheS*-containing plasmid, while those that
have excised the plasmid survive (51). The addition of a
second amino acid substitution in PheS* (deﬁned here
as PheS**) (52) confers even greater misincorporation of
4CP and higher counterselection efﬁciency and has been
successfully used in Streptococcus mutans (53) and in
S. pyogenes (Port and Caparon, unpublished) (Fig. 6). An
alternative counterselection strategy involves introduction of the rpsL marker into the ts vector (54). This gene
encodes ribosomal protein S12, and point mutations in
rpsL which render the ribosome resistant to the antibiotic streptomycin arise spontaneously in S. pyogenes at
a frequency of ∼10–9 cell–1 generation–1 (26). However,
in trans, the wild-type allele is dominant, so when a ts
vector containing wild-type rpsL is integrated into the
chromosome of a streptomycin-resistant strain, the resulting partial diploid will be sensitive to streptomycin.
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Despite the increase in time and effort, the construction
of in-frame deletions has become the standard for directed mutagenesis because they are stable and nonpolar. In-frame deletions have been constructed in the genes
for many S. pyogenes virulence factors, including the
C5a peptidase (16), the M protein, the cysteine proteinase (45), the has operon (46), and streptolysin O (47).
Most in-frame deletion mutations were constructed by
the method pioneered in the Cleary lab (16) that utilizes
a derivative of the ts plasmid pG+host4. In this method,
the gene of interest is cloned into the vector in E. coli.
Standard molecular techniques are then used to delete
a large central region of the gene, but at the same time
preserve its reading frame. Alternatively, a set of four
primers are designed to perform splicing by overlap extension (48) to directly generate the deletion construct
and insert it into the shuttle plasmid, all via PCR and
without the use of restriction digestion and ligation (49).
The resulting construct is introduced into an S. pyogenes
host at a temperature that is permissive for replication of
the plasmid. The culture is then shifted to the nonpermissive temperature while maintaining selection for the
resistance determinant of the plasmid. This selects for
chromosomes into which the nonreplicating plasmid has
been inserted by homologous recombination between the
in-frame deletion allele and the resident wild-type allele.
At this stage, the chromosome contains both the wildtype and deletion alleles. At some frequency, a second
homologous recombination occurs which results in the
excision of the integrated plasmid. Depending on the
recombination junctions, either the wild-type or the deletion allele remains behind in the chromosome (Fig. 5).

FIGURE 4 Directed insertional mutagenesis of targeted genes using circular DNA. (A) Insertional inactivation of the target gene. A
DNA segment internal to the target gene (shown by the gray box enclosed by wavy lines) is cloned onto an E. coli plasmid which
cannot replicate in S. pyogenes. The plasmid is introduced into an S. pyogenes host as a circular molecule (top of ﬁgure) with
selection for a resistance marker on the plasmid. A single homologous recombination event between the chromosome and the
circular molecule (shown by the “X”) results in the integration of the plasmid into the chromosome, a partial duplication of the gene
(the two regions shaded in gray) in which neither of the two copies are complete, resulting in gene inactivation. (B) Generation of
a polar insertion 3′ to the target gene. If the segment of DNA cloned on the integrational plasmid includes the 3′ terminus and
sequences downstream of the target gene (shown by the regions shaded in gray and the thick bar, respectively), homologous recombination (shown by the “X”) results in a partial gene duplication in which the 5′ copy is intact but the 3′ copy is truncated,
producing a polar eﬀect on any downstream gene(s) which may share a promoter in common with the target gene. When compared
with an insertion mutation that inactivates the target gene (Fig. 1 or Fig. 2), this strategy tests whether a phenotype is due to the loss of
target gene function or to a polar eﬀect on a distal gene. (C) Mapping the cis-acting control regions of the target gene. The technique
is modiﬁed by constructing several plasmids representing a nested set of the chromosomal region extending various distances 5′ of
the target gene. The plasmids are integrated into the target locus as described above, and the end-products are a partial duplication
of the target gene in which the proximal copy is truncated and inactive. If the duplicated region includes the cis-acting control regions
(represented by the broken arrow and the closed circle labeled “P”), the distal copy of the target gene will be expressed (scenario 1). In
contrast, if the cloned segment does not include the cis-acting control regions, then the distal copy will not be expressed (scenario 2).
Figure 4 continues on next page

10

ASMscience.org/MicrobiolSpectrum

Downloaded from https://journals.asm.org/journal/spectrum on 06 January 2022 by 128.252.174.220.

Cho et al.

FIGURE 4 (continued)

Thus, the inclusion of streptomycin during the ﬁnal
passage at the nonpermissive temperature directly selects
for chromosomes from which the integrated plasmid has
excised and segregated. This method has been used to
introduce mutant alleles of the virulence regulator Mga
into the chromosome for functional analyses (54).

In-Frame Deletion Using CRISPR/Cas9
A drawback to the standard in-frame deletion method
mentioned above is that it can be time-consuming, usually
taking more than a week for the multiple passages that
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are required to enrich for chromosomes that contain the
deletion allele (Fig. 5). This time period can be reduced
through the application of a system using clustered regularly interspaced short palindromic repeats (CRISPR)
and CRISPR-associated protein 9 (Cas9). CRISPR/Cas9
was originally described in S. pyogenes, where it functions
to confer an adaptive immunity against invading genetic
elements, especially bacteriophages (55, 56). It does this
by introducing double strand breaks at speciﬁc sequences
that the Cas9 enzyme is programmed to recognize by incorporation of a small targeting RNA molecule (CRISPR
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FIGURE 5 Construction of an in-frame deletion. Standard PCR-based methods are used to
generate a deletion of the internal region of a copy of the target gene that has been cloned
on an E. coli-streptococcal shuttle vector that is temperature-sensitive for replication (indicated by “ts ori”). The deletion is constructed so as to maintain the reading frame of the
gene (represented as the bent line labeled “R,” connecting the 5′ region labeled “A” and the
3′ region labeled “B”). Following its introduction into S. pyogenes, growth at a temperature
that is nonpermissive for replication of the plasmid with selection for the antibiotic-resistant
determinant of the plasmid (erm) selects for chromosomes in which the plasmid has integrated by homologous recombination (indicated by the “X”). The two regions of homology
ﬂanking the deletion are represented by the solid and gray bars labeled “A” and “B.” Recombination between the A bars or, alternatively, between the B bars (shown by the brackets
and arrows) results in excision of the plasmid and either the restoration of the wild-type
structure or allelic exchange for the deletion allele (these products are illustrated below the
second set of arrows). Growth at a temperature permissive for replication of the plasmid
enriches for excisant chromosomes, presumably because if integrated, the plasmid origin of
replication becomes active, resulting in misregulation of chromosomal replication. Presence
of the wild-type or deletion allele in any isolate is easily determined by assay for the unique
restriction site engineered into the deletion allele (indicated by the “R” above the bent line) or
by PCR with primers ﬂanking the region of interest.

RNA [crRNA]) that is encoded in the CRISPR array (55,
56).
To cleave a speciﬁc DNA site, the Cas9 nuclease associates with both a crRNA that has a short sequence
complementary to the DNA target sequence (known as
the proto-spacer) and with a separate trans-activating
crRNA (trRNA, sometimes called tracrRNA) (57). The
trRNA is partially complementary to the crRNA and is
required for crRNA maturation from a primary transcript
encoding pre-crRNAs. The crRNA and trRNA form a
12

based-paired structure that is incorporated into Cas9 and
targets the complex to a proto-spacer region located adjacent to a short motif known as the protospacer-adjacent
motif, which for S. pyogenes Cas9 is NGG. Jinek et al.
simpliﬁed the system by merging trRNA and crRNA into
a single synthetic molecule known as the single guide
RNA (sgRNA) (57). Due to its simplicity, requiring only
Cas9 and sgRNA, the type II CRISPR/Cas9 system from
S. pyogenes has found wide application for genome editing in many organisms, including higher eukaryotes
ASMscience.org/MicrobiolSpectrum
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FIGURE 6 PheS**, a counterselectable marker. The phenylalanyl tRNA synthetase (alpha subunit) PheS catalyzes the attachment of phenylalanine onto its cognate transfer RNA.
(A) Introduction of a single amino acid substitution (PheS*,
A314G) confers relaxed substrate speciﬁcity and allows for
the misincorporation of a toxic derivative of phenylalanine, 4chloro-phenylalanine (4CP), into proteins. Addition of a second substitution at position 260 (PheS**, either T260A or
T260S in combination with A314G) facilitates increased misincorporation of 4CP. (B) S. pyogenes containing a multicopy
plasmid (pABG5) either as an empty vector (WT) or engineered
to express PheS*, or PheS** was serial diluted and plated onto
solid media in the absence (top panel) or in the presence
(bottom panel) of 5 mM 4CP. Strains expressing PheS* show
moderate sensitivity to 4CP toxicity, whereas strains expressing
PheS** show enhanced sensitivity.

(58). A derivative, “dead” Cas9 (dCas9), modiﬁed by sitespeciﬁc mutations that inactivate its two nuclease activities,
can be used in a variety of approaches for silencing expression of speciﬁc genes (the CRISPRi method) (56, 59).
Cas9 can also be adapted for the efﬁcient construction
of in-frame deletions in S. pyogenes by providing a direct
ASMscience.org/MicrobiolSpectrum

counterselection against strains that retain the wild-type
allele. This method requires modiﬁcation of the standard
ts plasmid to contain Cas9 and an sgRNA in addition
to the in-frame deletion allele (K.H. Cho, unpublished).
The sgRNA should include a short ∼20-nucleotide sequence complementary to a sequence in the targeted gene
that will be eliminated by the deletion, which is adjacent
to a suitable protospacer-adjacent motif. When the plasmid is introduced into S. pyogenes with the wild-type
gene allele, only the strain with the in-frame deletion allele in its chromosome created by double-crossover survives, because it has eliminated the protospacer sequence.
In contrast, any strain retaining the wild-type allele is
killed due to the introduction of a double strand break
of its chromosome by the Cas9 nuclease. This process is
highly efﬁcient, because unlike most eukaryotic organisms that can repair a double strand DNA break through
nonhomologous end joining and homology-directed recombination (60), many prokaryotes use only homologydirected recombination to repair the double strand break.
Thus, if no homologous DNA is available for repair, the
double strand DNA break can be lethal (61). This method
has been successfully used to create in-frame deletions in
Staphylococcus aureus, Streptococcus pneumoniae, and
E. coli (62, 63). It is anticipated that this method will be
even more successful in S. pyogenes, because more than
half of the S. pyogenes genomes (14 out of 20 completely
sequenced and annotated strains available in GenBank
at the time of this writing) already possess cas9. For these
strains, just providing an sgRNA may be sufﬁcient for
selection of in-frame deletion mutants.

Considerations for Directed Mutagenesis
The multiple in vitro passages required for directed mutagenesis techniques have a tendency to enrich for spontaneous mutants with reduced expression of virulence
factors (64), including the M protein and the hyaluronic
acid capsule (65). It is therefore important to isolate and
phenotypically test multiple independently derived mutants to conﬁrm that they have a consistent phenotype, as
well as to genetically complement any mutants to conﬁrm that the targeted mutation is the cause of the observed phenotype. If the gene targeted for mutagenesis
lies upstream of an essential gene, it may be difﬁcult to
select for the initial single crossover due to a polar effect.
To counter this point, a larger DNA fragment encompassing the entire downstream gene can be utilized to
ensure continued gene expression following the initial
crossover (66). Finally, some mutants are less ﬁt and have
a slower growth rate than the wild type. Therefore, any
deletion mutants that are generated are quickly outcom13
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TRANSPOSON MUTAGENESIS
The techniques described above have been extremely
useful for the analysis of virulence in S. pyogenes. However, they require a detailed pre-existing knowledge of
the target gene and thus are more suited for reverse genetics approaches applied to testing hypotheses which
address the functions of previously identiﬁed and characterized genes or genes identiﬁed from whole-genome
sequence information whose function is suggested by
homology with a characterized gene. This approach is
not well suited for a forward genetics approach for the
identiﬁcation of novel genes that contribute to virulence.
This is most successfully done using a traditional unbiased genetic approach, in which a virulence phenotype
is established and random mutations are generated to
identify genes which inﬂuence this phenotype. In S. pyogenes, the most successful method of random mutagenesis has used the insertion of a transposable element at
multiple loci in the chromosome. This section considers
the various types of transposons that have been successfully used to identify novel genes in S. pyogenes, with
particular focus on recently adapted transposon systems
that allow for the characterization of high-diversity libraries, which include hundreds (signature tagged mutagenesis) or even thousands (TnSeq) of mutants during
infection.

Tn916
The ﬁrst transposable element used to identify novel
virulence genes in S. pyogenes was Tn916 (Fig. 7A). This
element is the prototype of the family of transposons
discovered by Clewell’s group (29), which are now known
as the conjugative transposons. They have the remarkable
property that they are self-transmissible and transpose
from a locus in a donor chromosome to a different locus
in a recipient chromosome when these chromosomes are
located in different cells. The conjugal transfer event requires cell-cell contact and can occur between very distantly related species and even between Gram-positive
and Gram-negative hosts. This biology of these unique
elements has been extensively investigated and is the subject of several excellent reviews (for example, 67) and thus
will only be brieﬂy mentioned here.
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The advantage to using Tn916 is that it can be applied
to probably any isolate of S. pyogenes, including those
which may be difﬁcult to transform. The disadvantages
are that Tn916 is a large element for a transposon (over
18 kb in size), does transpose into preferred sites, and
frequently generates chromosomes with multiple insertions. The transposon has served as a useful mutagenesis
agent and has been used to identify novel genes involved
in regulation (e.g., mga [7]), expression of streptolysin S
(68–70), and production of the capsule (71, 72), among
others.

Tn917
This transposable element was also originally described
by Clewell’s group in E. faecalis (73), highly engineered
by Youngman and colleagues, and applied with great
success to the mutagenesis of Listeria monocytogenes
and B. subtilis. One characteristic of this family is that
its members contain fairly large terminal repeats, although they are much smaller in size than the conjugative
transposons. They produce stable insertions, generate a 5bp target site duplication upon insertion, and transpose at
high frequency and with a high degree of randomness.
Their movement involves a replicative pathway, which
requires that donor and recipient molecules undergo replication, and proceeds through the cointegration of donor
and host molecules which contain two directly repeated
copies of the transposon at the fusion junctions. Resolution of the cointegrate occurs via site-speciﬁc recombination catalyzed by a transposon-encoded enzyme called
resolvase that recognizes a speciﬁc site in each copy of
the transposon (the res site). The end result is that a single
copy of the transposon is located at a random site in the
recipient molecule. Scott’s group (74) developed a mutagenesis vector (pJRS290) (75) that is based on pG+host4
and contains a highly engineered derivative of Tn917
developed by Youngman and coworkers (76) (Tn917LTV3) (Fig. 7B). This derivative of Tn917 has several
useful features, including an E. coli plasmid origin of replication that facilitates the direct cloning of chromosomal
DNA adjacent to the inserted transposon. Using this vector, Tn917-LTV3 was found to transpose efﬁciently and
with a high degree of randomness in S. pyogenes.

Tn4001
The transposable element Tn4001 was originally isolated as an agent of transmissible gentamycin-resistance
in S. aureus (77). It is a composite-type transposon and
a member of the Tn5 family. These transposable elements share a common structure in which directly repeated copies of an insertion sequence ﬂank an antibiotic
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peted by their wild-type counterparts, making them difﬁcult to recover following in vitro passage. In this case, an
allelic replacement mutant can be made whereby a gene
of interest is replaced by an antibiotic cassette, which
allows for direct selection of the mutated chromosome
(66).

FIGURE 7 Transposon mutagenesis of S. pyogenes. The several transposons that have been used for mutagenesis of S. pyogenes
are shown. Antibiotic resistance genes are represented by the gray bars, transposon ends and/or terminal inverted repeats are
shown in black, genes that are essential for transposition are shown by white bars, and genes that are nonessential for transposition are represented by the stripped bars. (A) Tn916 (GenBank accession no. U09422) is the prototype conjugative transposon
and contains at least 24 diﬀerent open reading frames. Of these, one is required for resistance to tetracycline, two are essential for
transposition, and the rest are likely involved in conjugal transfer. (B) Tn917-LTV3 is a highly engineered derivative of the Tn3-like
transposon Tn917. This element transposes via a replicative mechanism and has been modiﬁed to include a promoterless lacZ
reporter gene to generate random transcriptional fusions and an E. coli ColE1 plasmid origin of replication to facilitate the cloning
and analysis of inactivated loci. (C) TnSpc is a derivative of the Tn5-like transposon Tn4001, which transposes via a cut and paste
mechanism and consists of the left and right inverted repeats and transposase of IS256 and a spectinomycin resistance gene.
(D) TnFuZ introduces the gene for the E. faecalis alkaline phosphatase (phoZ) altered by removal of the region encoding its signal
sequence (broken line at the 5′ end of phoZ*). TnFuZ acts as an “export signal sequence trap.” Insertions into genes that encode a
protein export sequence promote the secretion of PhoZ* enzymatic activity, which can be detected by a number of highthroughput assays for alkaline phosphatase activity. (E) TmErm is an engineered element that contains the right and left mosaic
ends (ME) of Tn5 ﬂanking an erythromycin resistance marker (Ωerm) that includes strong transcription and translation stop sites
(Tx/Tn). To apply transposome mutagenesis to S. pyogenes, the DNA fragment containing TmErm is puriﬁed, such that the resulting preparation does not include the ampicillin resistance determinant contained on the pMOD-2::Ωerm vector backbone.
The puriﬁed DNA fragment containing TmErm is then reacted with transposase (EZ::TN, Epicentre Technologies) in vitro to form
the transposome that is then used to transform S. pyogenes using electroporation. (F) pOSKAR and pKRMIT are transposon
systems incorporated into the ts pWV01-based E. coli-streptococcal shuttle vector that utilize the highly active mariner Himar1
transposable element (MarC9) under control of the P23 promoter from Lactococcus lactis. Both transposon systems include a
kanamycin resistance gene (aphA3) ﬂanked by long terminal repeats (LTR) whose promiscuous target insertion site requires only a
TA dinucleotide sequence, leading to a highly random library of insertions. pOSKAR can be utilized for TraSH analysis through the
use of outward-facing T7 promoters, while pKRMIT also includes an outward-cutting MmeI site for use with TnSeq analysis.
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has been successfully applied to the identiﬁcation of genes
that promote pathogenesis in a zebraﬁsh model of S.
pyogenes infection (79, 80).

TnFuZ
Since the terminal inverted repeats of IS256 are quite
short (26 bp), several specialized derivatives of the transposon have been developed that place a reporter gene
adjacent to the IS256 end. The TnFuZ (fusion to phoZ)
reporter places a version of the E. faecalis phoZ alkaline
phosphatase adjacent to the transposon inverted repeat
(Fig. 7D). This reporter gene has been modiﬁed by removal of its endogenous export signal sequence to construct an “export signal sequence trap.” In this method,
insertion of the element into an open reading frame can
result in the formation of a translational fusion with
PhoZ (the use of PhoZ as a reporter gene is discussed
below). If the donor open reading frame contains a secretion export signal, the chimeric PhoZ protein will be
secreted. Since PhoZ is only active following its export
across the cytoplasmic membrane, a simple and rapid
colorimetric screen can be used to identify colonies arising
from a mutant that contains an insertion in a gene that
encodes a secreted protein. The TnFuZ element has been
used to identify secreted proteins whose expression is enhanced during aerobic growth (81). Another example of
the versatility of IS256-based elements is those that have
been modiﬁed to include genes encoding a bacterial luciferase (use of luciferase as a reporter gene is discussed
below). Insertion into a transcription unit that directs
transcription of the luciferase genes allows gene expression in vivo to be monitored noninvasively using specialized imaging cameras that can capture photons emitted by
the streptococci in living host tissue (82).

Transposome Mutagenesis
In transposome mutagenesis, a stable complex between
transposase and transposon DNA is formed in vitro and
then introduced into a bacterium. The elevated concentration of Mg2+ in the bacterial cytoplasm activates
transposase that then catalyzes transposition of the element to some random location in the bacterial chromosome. This method has been adapted for efﬁcient
mutagenesis of S. pyogenes (43). For this, a streptococcal
erythromycin-resistance gene was introduced between
the inverted repeats of a derivative of Tn5 (EZ-TN5tm)
on the E. coli plasmid pMOD-2 (Epicentre Technologies) to construct TmErm (Fig. 7E) (43). Following digestion with a restriction endonuclease, the transposon
(TmErm)-containing linear DNA fragment is reacted with
a modiﬁed hyperactive transposase (EZ::TN, Epicen-
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resistance gene. Each insertion sequence itself is bounded
by short inverted repeats that ﬂank a transposase gene,
which is the only transposon-encoded gene required
for movement. The individual insertion sequences themselves are usually capable of transposition independent of
the entire element. For Tn4001, two copies of the insertion sequence IS256 ﬂank a central gentamycin-resistance
gene. The transposition pathway for this class of elements
involves a “cut and paste” mechanism catalyzed by the
transposase, which recognizes as its substrates the short
inverted repeats of the insertion sequences. Studies have
shown that Tn4001 has a broad host range, including
staphylococci, oral streptococci, and mycoplasmas, and
that it chooses its targets for insertion with a high degree
of randomness. Since the cut and paste pathway does not
require replication of the donor molecule, the element can
easily be delivered into the host of choice via a nonreplicating suicide vector. However, a number of problems
have limited its use. The most signiﬁcant of these is that
transposition of the entire element occurs at a somewhat
low frequency relative to the frequency of transposition of
the individual insertion sequences. As a result, a chromosome with a Tn4001 will frequently also have multiple copies of IS256 inserted at other loci. To address this
problem, derivatives of Tn4001 have been constructed
that essentially contain only the inverted repeats of IS256
oriented to ﬂank the gene for transposase and a selectable
marker (78). The resulting elements are relatively small in
size (∼2 kb) and transpose at a high frequency characteristic of an individual copy of IS256. The organization
of the element also prevents independent transposition
of the insertion sequence and ensures that the resulting
population of insertions is homogeneous, although the
resulting mutants may have insertions at two loci. A
spectinomycin-resistant version of this transposon (called
TnSpc for simplicity) (Fig. 7C) was used to identify novel
genes required for expression of the SpeB cysteine protease of S. pyogenes, including a transcriptional regulator
(ropB) and a chaperone (ropA) (78). Additional variants
include the introduction of an erythromycin resistance
gene and 1 of 12 unique 34-bp signature tags for application in signature-tagged mutagenesis studies. In this
method, 12 independent pools of mutants are generated.
Then, one mutant is taken from each of these pools, and
they are combined to generate an inoculum with 12-fold
complexity that is used as the input into an assay of virulence. The output pool is then analyzed by a PCR assay
to conduct a census of the recovered sequence tags, which
is then compared with the input pool to determine the
relative ﬁtness of individual mutants. Mutants with reduced ﬁtness are putative virulence genes, and this method

Genetics of Group A Streptococci

Himar1-Based Mariner Transposon Systems
While the generation of a complex transposon library is
relatively straightforward, mapping the location of the
insertion site in the chromosome of any single mutant has
historically been quite laborious. Prior to the development
of rapid and relatively low-cost whole-genome sequencing technology, arbitrary PCR (78) was usually utilized to
map the site of transposon insertion. An adaptation of this
method for rapid screening using pools of mutants was a
form of microarray-based analysis known as transposon
site hybridization, utilizing a transposon with outwardfacing T7 promoters at ﬂanking ends (pOSKAR) (Fig. 7F)
(83). Later, this transposon platform was modiﬁed to
allow for analysis by high-throughput next-generation
sequencing through the use of an outward-cutting restriction enzyme known as MmeI for the technique known as
TnSeq (pKRMIT) (Fig. 7F) (84). Both of these transposon
platforms utilize the highly active and promiscuous mariner Himar1 transposable element, whose target insertion
site requires only a thiamine-adenine (TA) dinucleotide
sequence, leading to a highly random library of insertions.
Le Breton and McIver’s group developed a Marinerbased system for use in S. pyogenes by introducing the
mariner transposon into the ts pWV01 shuttle vector.
Because the transposon is highly active, propagation of
the shuttle vector in E. coli is unstable and requires careful screening of preparations of puriﬁed plasmid to ensure
that the correct plasmid structure has been maintained
prior to electroporation into S. pyogenes (12). Furthermore, transposition likely occurs quite rapidly relative to
the rate of plasmid loss following growth at restrictive
plasmid temperatures. Therefore, additional screening is
required for the subsequent S. pyogenes mutant pools
prior to phenotypic testing. Despite these technical limitations, multiple labs have used this transposon system
for transposon site hybridization analysis utilizing the
plasmid pOSKAR to screen for genes required for growth
in human blood (25), to identify regulators of the Rgg
quorum sensing system (85, 86), and for TnSeq analysis
utilizing the plasmid pKRMIT for analysis of core essential genes required for growth in vitro (42) and for
murine soft-tissue infection (87).
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Analysis of Transposon Mutants
Regardless of the type of transposable element utilized,
there are a number of additional tests that should be
performed to ensure that the mutant phenotype is the
direct result of insertion of the transposon. This involves
determining the sequence of the locus into which the
transposon has inserted via arbitrary PCR, inverse PCR
after enzyme digestion and ligation, or whole-genome
sequencing. With this data in hand, the next step is to
construct a mutant in the locus in the wild-type parental
strain using one of the strategies for directed mutagenesis outlined above. If the original insertion is responsible for the mutant phenotype, then it is expected that all
isolates obtained via directed mutagenesis will also be
mutants. It should also be kept in mind when interpreting results that transposon-generated mutations are
also polar, so the gene(s) responsible for the observed
phenotype may lie downstream of the interrupted gene.

ANALYSIS OF GENE EXPRESSION
Gene regulation phenomena play a key role in pathogenesis. The interaction between the host and the microbe is dynamic and often is a progression through a
number of discrete steps. Each of these steps is characterized by the expression of speciﬁc sets of bacterial genes
required for survival and multiplication and the host’s
response to the action of the products of these microbial
genes. As a consequence, the microorganism is continually challenged to adapt to new and changing environmental conditions. Pathogens have taken advantage of
the dynamic nature of this interaction and have evolved
to recognize changes in speciﬁc environmental conditions
as markers that deﬁne a particular host compartment or
stage of infection. The pathogen uses this information to
modulate expression of virulence genes required for survival in this host compartment. Thus, an understanding
of the in vitro conditions that regulate expression of a
speciﬁc virulence gene provides insight into how the gene
contributes to virulence in vivo (for review see 88). Regulation of virulence genes often involves control at the
level of transcription. For S. pyogenes, transcriptional
regulation has often been analyzed through the use of
reporter genes, particularly in studies designed to determine the speciﬁc conditions that activate or repress expression of a gene of interest.
The basic strategy for using reporter genes to analyze
gene expression involves fusing the promoter for the
virulence gene of interest to a reporter gene that encodes
a gene whose product can easily be quantitated. This
feature is of particular utility when the assays for quan-
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tre Technologies) to generate the transposome. Following transformation of S. pyogenes using electroporation,
erythromycin-resistant colonies were obtained at frequencies between 103 and 104 CFU/μg DNA (43). Mutations generated by this method have proven to be very
stable even in the absence of erythromycin selection,
possibly because the inserted transposon does not encode its own transposase.

titation of the product of the streptococcal gene under
analysis are time-consuming, expensive, and/or cumbersome. The reporter gene lacks its own promoter, so its
product becomes an accurate relative indicator of the
steady state level of transcription initiation from the target promoter. It should be kept in mind that because
the message is a chimera between the initiation signals
of the target gene and the reporter gene, it is not subject
to the same posttranscriptional and posttranslational
controls. Furthermore, the half-life of the reporter gene’s
translation product does not reﬂect that of the native
polypeptide. Thus, reporter genes are most appropriately
used to quantitate the strength of initiation of transcription of the target promoter.
The reporter genes that have been successfully used
in S. pyogenes include chloramphenicol acetyltransferase
(Cat), β-galactosidase (Lac), β-glucuronidase (Gus), alkaline phosphatase (Pho), and bacterial luciferase (LuxAB).
The products of all these genes are stable, highly active
enzymes that are highly speciﬁc for their substrates. Their
utility is enhanced by the availability of synthetic substrates
with isotopic, colorimeteric, ﬂuorogenic, or light-emitting
properties that allow very sensitive detection. Also, the
reporter genes encoding these enzymes are derived from
Gram-positive bacteria or have been extensively modiﬁed
to optimize their expression in Gram-positive hosts and
differ extensively from their counterparts used for analysis in E. coli.
The most successful applications of Cat have employed
cat86, originally isolated from Bacillus pumilus, which has
been modiﬁed by the deletion of an attenuator sequence
and the substitution of an adenine-thiamine-guanine
(ATG) start codon for the native gene’s thiamine-thiamineguanine (TTG) start codon. The advantages of Cat are that
cat86 is very stably maintained in S. pyogenes and that the
assays for its enzymatic acetylation of chloramphenicol are
very sensitive (89, 90). It has several disadvantages: the
most sensitive assays involve radioactivity, are expensive,
are somewhat labor-intensive relative to other reporter
genes, and require the preparation of cell-free extracts.
Both Lac and Gus utilize E. coli genes that have been
modiﬁed by the introduction of ribosome binding sites
recognized by Gram-positive bacteria (91, 92). The advantages to using these as reporters are that assays for their
enzymatic activities are easy to perform and rapid and
many samples can be analyzed simultaneously, that a wide
variety of substrates is available, and that it is possible to
analyze both permeabilized cells and cell extracts. Disadvantages are that they are not as sensitive or as stably
maintained in S. pyogenes as cat86. Nevertheless, gusA
has proven to be very useful in numerous applications,
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including identiﬁcation of regulatory sites in the hasA
promoter (93) and to ﬁnd a regulator (rocA) that modulates transcription of the CovRS two-component global
regulator of virulence and stress resistance (94).
The LuxAB bacterial luciferase, originally from Vibrio ﬁscheri, has found utility in dissecting the mechanism
of Rgg-associated signaling peptides in S. pyogenes (35).
An advantage of a luciferase reporter is that the assay is
extremely sensitive and quantitative, because exposure
of bacterial cultures to volatile decyl aldehyde (decanal)
for less than one minute can result in a measurable light
output. A disadvantage of this reporter is that luciferase
activity is growth phase sensitive due to the reaction’s
requirement for reduced ﬂavin mononucleotide as a cofactor (95) and has been shown to fail in some bacteria
during the stationary phase (82) or under conditions of
low pH or oxidative stress (96).
A chimeric reporter protein based on fusion of two
naturally secreted proteins has also been developed. This
reporter contains as its enzymatic partner, the alkaline
phosphatase of E. faecalis (PhoZ) (97). This enzyme is
secreted from E. faecalis and is a lipoprotein that becomes tethered to the outer leaﬂet of the cell membrane.
Fusing the enzymatic C-terminal domain of PhoZ, not
including its lipoprotein secretion signal, to the nonlipoprotein N-terminal secretion domain of protein F of S.
pyogenes results in a very stable, highly enzymatically
active chimeric protein (PhoZF) (Fig. 1) which is freely
secreted from the streptococcal cell into the surrounding
medium (20). This feature makes quantitative analysis of
the secreted chimeric protein in culture supernatant very
simple and requires neither permeabilization nor preparation of cytoplasmic extracts. Due to the widespread
popularity of alkaline phosphatase enzymes, an excellent
selection of sensitive substrates with a variety of useful characteristics, including those with ﬂuorescent and
light-emitting properties, are inexpensive and are readily
available.
Green ﬂuorescent protein (GFP) has become a widely
used reporter of gene expression because of its ease of
detection and its utility for application in real-time assays for analyses in vitro and in vivo during infection.
Numerous versions of GFP are available that have been
modiﬁed to alter codon usage, stability, and spectral
properties (98). The GFPuv variant has been used to
examine regulation of the promoter for the hyaluronic
acid biosynthesis gene cluster in streptococci recovered
directly from infected tissues (99). This latter study also
reported an important consideration for interpreting
data derived from GFP-based reporters in that ﬂuorescence is often not uniform among streptococcal cells in
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RT-PCR is used for validation expression of individual genes of interest from data developed from RNAseq
analyses (102). In quantitative real-time RT-PCR, total
RNA is puriﬁed and then converted to ﬁrst-strand complementary DNA (cDNA) using reverse transcriptase.
These cDNAs then serve as a template for real-time PCR
using primers speciﬁc for the gene in question. Real-time
thermocyclers are modiﬁed with a detection system that
can continuously monitor the ﬂuorescence of a probe
that is sensitive to the quantity of DNA that is being
synthesized by PCR, and the ampliﬁcation cycle at which
a detectable ampliﬁcation product is ﬁrst detected is a
quantitative measure of the concentration of that message
in the input cDNA pool. Data are typically reported as a
ratio to a reference gene such as recA or gyrA whose expression is relatively constant under analysis conditions.

Techniques for Ectopic Expression
Structure-function studies of the role of putative virulence
factors require techniques for ectopic expression, both to
control the timing and relative levels of expression of a
given gene and to study the structure-function relationships of speciﬁc domains of a given virulence-associated
protein. The former case requires the availability of an
ectopic promoter whose activity can be tightly, easily, and
quantitatively controlled by some external factor. The
latter case requires a method for the expression of various
domains of the polypeptide under analysis into the context
of an unrelated polypeptide. This allows an independent
analysis of the functionality of that domain separate from
other regions of the original polypeptide. Methods to accomplish both of these expression strategies have been
developed for analysis of virulence in S. pyogenes.
An initial approach for using a regulated heterologous
promoter to direct expression of the gene under analysis
was based on the nisA promoter of Lactococcus lactis. In
lactococci, the NisR/K two-component system controls
the expression PnisA in direct response to nisin concentration. The method for using this regulated promoter
involves the introduction of nisK and nisR into an S.
pyogenes strain, while the gene of interest is introduced
under control of the nisA promoter, which makes expression of the gene of interest sensitive to the concentration of exogenous nisin that is added to the culture.
Tightly regulated expression of a gusA reporter gene and
induction of up to 60-fold over background using a
broad range of nisin concentrations has been reported for
S. pyogenes (74). The NisR/K system has some drawbacks, including the stability of nisin (103) and a relatively
high basal level of expression in the uninduced state,
which makes conditional expression of putative essential
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any population, including many cells that express no detectable ﬂuorescence (99). It is likely that the microaerophilic or anaerobic conditions that are typically used
for culturing S. pyogenes are not ideal for GFP maturation, since oxygen is required for GFP chromophore
formation. However, a more stable variant known as
superfolder GFP has shown utility in several applications
in S. pyogenes, including monitoring subcellular localization of proteins (100).
Numerous strategies have been used to introduce reporter fusion constructs into S. pyogenes for analysis.
Plasmid vectors have the advantage that they are easy
to manipulate and can be used to generate and analyze
a large number of permutations and variations of promoter structure to probe the cis and trans-acting control
regions. A plasmid-based reporter is present in multiple
copies, and this ampliﬁcation increases the sensitivity
of detecting the activity of the promoter under analysis.
This latter feature can also make plasmid-based systems
sensitive to multiple-copy-number-derived artifacts, such
as titration of trans-acting regulatory components, when
those components are only present in limiting quantities. Furthermore, any sequence-directed local effects of
chromosomal structure on expression of a given promoter
will not likely be replicated in a plasmid environment.
Integration of reporter constructs into the chromosome
can alleviate many of these latter types of potential artifacts but with a trade-off in ease of use and sensitivity.
Integration is usually performed by introducing the reporter construct on a nonreplicating E. coli-based plasmid to target integration into the target gene’s native
locus by homologous recombination promoted by the
cloned promoter segment. Alternatively, use of the integrating p7INT/p7INT* plasmid can reproduce a more
native chromosomal environment through integration at
the attB site (Fig. 2).
Next-generation sequencing approaches such as RNA
seq for global analysis of the transcriptome coupled with
quantitative real-time RT-PCR methods have recently
become the standard for analysis of gene expression in
S. pyogenes. Although it requires preexisting knowledge
of the genome sequence, this disadvantage is more than
offset by the facts that RNAseq does not require the laborious construction of reporter gene fusions, that it is
fast and easy to perform, that it can directly analyze the
entire transcriptome, including novel RNA species, and
that it is not limited to the genes for which probes were
designed. RNA analysis has been greatly facilitated by
the development of technology for the simple and rapid
puriﬁcation of high-quality RNA from relatively small
samples (101). In practical terms, quantitative real-time
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ogous sequence without affecting expression and surface
presentation of the resulting chimera. Essentially, the heterologous domain is placed between the N-terminal secretion and C-terminal attachment domains of M protein
to display the heterologous domain on the streptococcal
cell surface. A successful application of this strategy involved analysis of the two distinct ﬁbronectin-binding
domains of protein F (110). For a more detailed explanation of this technique see Hanski et al. (39).

CONCLUDING REMARKS
Rapid progress has been made in recent years in the development of sophisticated techniques for genetic analysis
in S. pyogenes. Much of this effort has been directed at
the development of methods for the mutagenesis of
known genes. Considerable progress has also been made
in the development of strategies for the identiﬁcation of
novel genes. It is likely that the widespread application of
these techniques to the virulence properties of S. pyogenes
will enrich our understanding of streptococcal pathogenesis with insight at the molecular level and will help
to establish and clarify the contributions of speciﬁc
genes. Additional use and development of methods for
the analysis of gene expression and heterologous expression will continue and will allow analyses of virulence factors at much higher levels of resolution than
previously possible.
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